keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Labradimil is a bradykinin B2 receptor agonist. Labradimil increases the permeability of human brain microvascular endothelial cell monolayers. Labradimil enhances delivery of hydrophilic chemotherapeutics and increases survival in rats with metastatic tumors in the brain. Labradimil increases carboplatin levels in brain tumors after pretreatment with dexamethasone.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | お問い合わせ | ¥ 349,000 |
50 mg | お問い合わせ | ¥ 454,500 |
100 mg | お問い合わせ | ¥ 574,000 |
説明 | Labradimil is a bradykinin B2 receptor agonist. Labradimil increases the permeability of human brain microvascular endothelial cell monolayers. Labradimil enhances delivery of hydrophilic chemotherapeutics and increases survival in rats with metastatic tumors in the brain. Labradimil increases carboplatin levels in brain tumors after pretreatment with dexamethasone. |
別名 | RMP-7, ALK-01-040, Receptor-mediated permeabiliser-7, DRG0182, DRG 0182, DRG-0182 |
分子量 | 1098.29 |
分子式 | C49H75N15O12S |
CAS No. | 159768-75-9 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Labradimil 159768-75-9 RMP-7 ALK-01-040 RMP 7 Receptor-mediated permeabiliser-7 DRG0182 DRG 0182 RMP7 DRG-0182 Inhibitor inhibitor inhibit